Log In
BCIQ
Print this Print this
 

ApoGraft

  Manage Alerts
Collapse Summary General Information
Company Cellect Biotechnology Ltd.
DescriptionMobilized peripheral blood cells (MPBC) for stem cell transplantation which are exposed to Fas ligand (TNF superfamily, member 6) (FASL) to induce apoptosis in mature T cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsPrevent graft-versus-host disease (GvHD) in allogeneic marrow transplants
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today